Variants in autophagy-related genes and clinical characteristics in melanoma: a population-based study

Authors

Kirsten A. M. White, Li Luo, Todd A. Thompson, Salina Torres, Chien-An Andy Hu, Nancy E. Thomas, Jenna Lilyquist, Hoda Anton-Culver, Stephen B. Gruber, Lynn From, Klaus J. Busam, Irene Orlow, Peter A. Kanetsky, Loraine D. Marrett, Richard P. Gallagher, Lidia Sacchetto, Stefano Rosso, Terence Dwyer, Anne E. Cust, Colin B. Begg, Marianne Berwick, and for The GEM Study Group

 

• First published: 17 October 2016
• DOI: 1002/cam4.929

 

---

Oncotarget

Deregulation of miR-183 promotes melanoma development via lncRNA MALAT1 regulation and ITGB1 signal activation

Yong Sun^1,*, Hongyu Cheng^1,*, Guangjun Wang¹, Guojun Yu¹, Dawei Zhang¹, Yibing Wang¹, Wei Fan², Weixi Yang¹

Received: September 01, 2016????Accepted: November 22, 2016????Published: December 10, 2016

---

Scandinavian Journal of Rheumatology

Successful treatment with intravenous cyclophosphamide for anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis associated with myelodysplastic syndrome

T Nawata, M Kubo, S Okuda, M Omoto, T Yujiri, T Kanda & M Yano 

Pages 1-3 | Accepted 24 Oct 2016, Published online: 09 Dec 2016

---

BRAF inhibitors and radiotherapy for melanoma brain metastases: potential advantages and disadvantages of combination therapy

Authors Chowdhary M, Patel KR, Danish HH, Lawson DH, Khan MK

Received 10 August 2016

Accepted for publication 20 October 2016

Published 12 December 2016 Volume 2016:9 Pages 7149—7159

DOI https://doi.org/10.2147/OTT.S119428

---

Evaluation of ?-cyclodextrin-modified gemini surfactant-based delivery systems in melanoma models

Authors Michel D, Mohammed-Saeid W, Getson H, Roy C, Poorghorban M, Chitanda JM, Verrall R, Badea I

Received 31 August 2016

Accepted for publication 15 October 2016

Published 12 December 2016 Volume 2016:11 Pages 6703—6712

DOI https://doi.org/10.2147/IJN.S121156

---

­­­­­­­­­­­­­­

Immunotherapy in the Precision Medicine Era: Melanoma and Beyond

Mack Y. Su,

David E. Fisher

 

 

Published: December 13, 2016

http://dx.doi.org/10.1371/journal.pmed.1002196

---

The protein phosphatase 2A regulatory subunit PR70 is a gonosomal melanoma tumor suppressor gene

1. Léon C. L. van Kempen¹,²,
2. Margaret Redpath¹,²,
3. Mounib Elchebly²,
4. Kathleen Oros Klein²,
5. Andreas I. Papadakis¹,²,
6. James S. Wilmott³,
7. Richard A. Scolyer³,
8. Per-Henrik Edqvist⁴,
9. Fredrik Pontén⁴,
10. Dirk Schadendorf⁵,⁶,
11. Anke F. van Rijk²,
12. Stefan Michiels⁷,⁸,
13. Anne Dumay⁹,
14. Anne Helbling-Leclerc¹⁰,¹¹,
15. Philippe Dessen¹²,
16. Jasper Wouters¹³,¹⁴,¹⁵,
17. Marguerite Stass¹⁶,
18. Celia M. T. Greenwood²,¹⁷,¹⁸,
19. Ghanem E. Ghanem¹⁹,
20. Joost van den Oord¹³,
21. Jean Feunteun¹¹and 
22. Alan Spatz¹,²,¹⁷,*

 

Science Translational Medicine  14 Dec 2016:
Vol. 8, Issue 369, pp. 369ra177
DOI: 10.1126/scitranslmed.aai9188

---

Genes 2016, 7(12), 124; doi:10.3390/genes7120124

microRNA Expression in Sentinel Nodes from Progressing Melanoma Patients Identifies Networks Associated with Dysfunctional Immune Response

Viviana Vallacchi ^1,†

,Chiara Camisaschi ^1,†

,Matteo Dugo ^2,†

,Elisabetta Vergani ^1,†

,Paola Deho ¹

,Ambra Gualeni ³

,Veronica Huber ¹

,Annunziata Gloghini ³

,Andrea Maurichi ⁴

,Mario Santinami ⁴

,Marialuisa Sensi ²

,Chiara Castelli ¹

,Licia Rivoltini ¹

 andMonica Rodolfo ^1,* 

---

Weight control interventions improve therapeutic efficacy of dacarbazine in melanoma by reversing obesity-induced drug resistance

• Parmanand Malvi,
• Balkrishna Chaube,
• Shivendra Vikram Singh,
• Naoshad Mohammad,
• Vimal Pandey,
• Maleppillil Vavachan Vijayakumar,
• Revathy Meenatheril Radhakrishnan,
• Muralidharan Vanuopadath,
• Sudarslal Sadasivan Nair,
• Bipin Gopalakrishnan Nair and
• Manoj Kumar Bhat

Cancer & Metabolism20164:21

DOI: 10.1186/s40170-016-0162-8

Received: 9 July 2016

Accepted: 23 November 2016

Published: 7 December 2016

---

The BMJ

Training partners to look for melanoma signs does not increase embarrassment, study shows

BMJ 2016; 355 doi: http://dx.doi.org/10.1136/bmj.i6692 (Published 19 December 2016)Cite this as: BMJ 2016;355:i6692

---

Optimizing Outcomes for Cutaneous Head and Neck Melanoma

Karen L. Connolly, MD¹; Klaus J. Busam, MD²; Kishwer S. Nehal, MD¹

Author Affiliations Article Information

JAMA Dermatol. Published online December 21, 2016. doi:10.1001/jamadermatol.2016.4604

---

Antiproliferative and Pro-Apoptotic Effects of MiR-4286 Inhibition in Melanoma Cells

• Anna Komina,
• Nadezhda Palkina,
• Mariya Aksenenko,
• Seseg Tsyrenzhapova,
• Tatiana Ruksha

 

 

• Published: December 22, 2016
• http://dx.doi.org/10.1371/journal.pone.0168229

---

Trends in mortality rates of cutaneous melanoma in East Asian populations

Ling Chen?, Shaofei Jin

Published December 22, 2016

PubMed 28028475

---

Pulmonary Infiltrates in a Patient With Advanced Melanoma

Charles A. Powell

DOI: 10.1200/JCO.2016.69.9793 Journal of Clinical Oncology – published online before print December 28, 2016

---

Comparison of Regional and State Differences in Melanoma Rates in the United States2003 vs 2013

Jessica S. Mounessa, BS^1,2; Joseph Vincent Caravaglio, BA³; Robert P. Dellavalle, MD, PhD, MSPH

JAMA Dermatol. Published online December 28, 2016. doi:10.1001/jamadermatol.2016.4625

---